🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

5,609 results for “AB” Clear

  1. [14C]HSK7653

    The First People's Hospital of Lianyungang

    Type II Diabetes

    phase 1 small molecule completed

    1 trial

  2. [68Ga]Ga-Sa-DABI-4

    The First People's Hospital of Lianyungang

    Stimulator of Interferon Gene

    phase 1 small molecule active

    1 trial

  3. [F18]-ASEM (3-(1,4-diazabicyclo[3.2.2]nonan-4-yl)-6-[18F]fluorodibenzo[b,d]thiophene 5,5-dioxide)

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Use Disorder

    phase 1 small molecule completed

    1 trial

  4. a 60 mg dose of the hydrocodone bitartrate extended-release tablet administered as either two 30-mg tablets (Treatment A) or one 60-mg tablet (Treatment B).

    Teva Pharma GmbH

    Pain

    phase 1 small molecule completed

    1 trial

  5. administration of UI068

    United Therapeutics Europe Ltd

    Diabetes Mellitus, Type 2

    phase 1 small molecule completed

    1 trial

  6. ateganosine

    MAIA Biotechnology

    Resectable Hepatocellular Carcinoma

    phase 1 small molecule active

    1 trial

  7. autologous decidual-like NK cells

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Abortion, Habitual

    phase 1 mab active

    1 trial

  8. avoralstat

    Biocryst

    Diabetic Macular Edema (DME)

    phase 1 small molecule terminated

    1 trial

  9. blinatumomab and auto-HSCT "sandwich " strategy

    The First People's Hospital of Lianyungang

    B-cell Acute Lymphoblastic Leukemia

    phase 1 other active

    1 trial

  10. brontictuzumab

    Mereo BioPharma Group plc

    Metastatic Colorectal Cancer

    phase 1 small molecule completed

    1 trial

  11. buprenorphine

    BRIGHT MINDS BIOSCIENCES INC.

    Neonatal Abstinence Syndrome

    phase 1 small molecule completed

    1 trial

  12. cannabis

    BRIGHT MINDS BIOSCIENCES INC.

    Behavioral Pharmacology of Cannabis

    phase 1 small molecule completed

    1 trial

  13. cemiplimab

    Regeneron UK Limited

    Relapsed/Refractory Aggressive B-Cell Lymphoma

    phase 1 small molecule active

    1 trial

  14. dMAb AZD5396

    INOVIO PHARMACEUTICALS, INC.

    Healthy Volunteers

    phase 1 other completed

    1 trial

  15. decitabine

    Karyopharm Therapeutics Inc

    Acute Myeloid Leukemia

    phase 1 small molecule completed

    1 trial

  16. delta 9 tetrahydrocannabinol

    BRIGHT MINDS BIOSCIENCES INC.

    COMT Gene Polymorphism

    phase 1 small molecule completed

    1 trial

  17. drug condition

    BRIGHT MINDS BIOSCIENCES INC.

    Cannabis

    phase 1 small molecule completed

    1 trial

  18. hVEGF-A

    SANGAMO THERAPEUTICS, INC

    Diabetic Neuropathy

    phase 1 gene therapy completed

    1 trial

  19. iloperidone (oral tablet)

    Vanda Pharmaceuticals Netherlands B.V.

    Safety and Tolerability of Iloperidone

    phase 1 small molecule completed

    1 trial

  20. linvoseltamab

    Regeneron UK Limited

    Food Allergy

    phase 1 small molecule active

    1 trial

  21. liposomal cytarabine

    Pacira Ireland Limited

    Brain and Central Nervous System Tumors

    phase 1 small molecule active

    1 trial

  22. mHealth application (custom)

    BRIGHT MINDS BIOSCIENCES INC.

    Cognitive Function Abnormal

    phase 1 other completed

    1 trial

  23. metformin hydrochloride 500 mg tablet

    PMV Pharmaceuticals

    TP53 Y220C Mutation

    phase 1 small molecule active

    1 trial

  24. milatuzumab

    United Therapeutics Europe Ltd

    Lupus Erythematosus, Cutaneous

    phase 1 small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources